Ownership and insider activity for Lucyd, Inc (LUCY): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses under the Lucyd Lyte, Lucyd Armor, Nautica, Eddie Bauer, and Reebok brand names.
Price
| Price | $0.86 |
| Market Cap | $5M |
| Exchange | NASDAQ |
| Country | US |
Balance Sheet (10y)
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 0 | $27023 | $79727 | $3.6M | $4.3M | $2.6M | $6.5M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | $4.9M | 0 |
| Receivables | 0 | 0 | $43394 | $110258 | $93211 | $131312 | $476734 |
| Inventory | 0 | $89780 | $275501 | $94701 | $856759 | $831757 | $1.7M |
| Total Current Assets | 0 | $141803 | $644327 | $4.2M | $5.6M | $9.2M | $9.4M |
| Property, Plant & Equipment | 0 | 0 | $20284 | $119745 | $132848 | $107562 | $61777 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | $69213 | $159706 | $247630 | $396502 | $451302 | $559968 |
| Total Assets | 0 | $231663 | $824317 | $4.7M | $6.2M | $9.8M | $10.1M |
| Accounts Payable | 0 | $51410 | $167050 | $275660 | $581986 | $692817 | $985417 |
| Short-term Debt | 0 | $599542 | $289029 | $61356 | 0 | 0 | 0 |
| Total Current Liabilities | $483825 | $765853 | $616801 | $600005 | $624486 | $737718 | $1.0M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $483825 | $765853 | $616801 | $665455 | $659936 | $743168 | $1.1M |
| Retained Earnings | -$611464 | -$1.4M | -$4.6M | -$10.3M | -$17.0M | -$24.7M | -$32.3M |
| Total Equity | -$483825 | -$534190 | $207516 | $4.0M | $5.6M | $9.1M | $9.1M |
| Total Debt | 0 | $599542 | $289029 | $61356 | 0 | 0 | 0 |
| Net Debt | 0 | $572519 | $209302 | -$3.5M | -$4.3M | -$7.5M | -$6.5M |
| Working Capital | -$483825 | -$624050 | $27526 | $3.6M | $5.0M | $8.5M | $8.4M |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 12.06 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -3.75 |
Profitability
| Return on Equity | -88.90% |
| Return on Invested Capital | -122.15% |
| Return on Assets | -102.86% |
| Gross Margin | 22.79% |
| Operating Margin | -249.03% |
| Net Margin | -225.28% |
Related companies: APRE · BCDA · BMRA · CELZ · CHEK · KPRX · MHUA
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of LUCY: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks